Cargando…
Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS
Moderate to severe chronic graft-versus-host disease (cGVHD) is associated with high morbidity, hospital dependency and poor quality of life. In this study, we analyzed a well-defined consecutive series of 98 patients with acute myelogenous leukemia/myelodysplastic syndrome (AML/MDS) who received al...
Autores principales: | Kok, Laurence M. C., Bungener, Laura, de Bock, Geertruida H., Biswana, Anouschka, van der Wal, Geertiena, van Imhoff, Gustaaf W., Bellido, Mar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965489/ https://www.ncbi.nlm.nih.gov/pubmed/31732859 http://dx.doi.org/10.1007/s13577-019-00297-7 |
Ejemplares similares
-
SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS
por: Luger, Selina M., et al.
Publicado: (2011) -
Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy
por: Yang, Guancui, et al.
Publicado: (2022) -
Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML
por: Cao, Xing-yu, et al.
Publicado: (2023) -
Inherited predisposition to MDS/AML
por: Rio Machin, Ana, et al.
Publicado: (2018) -
IRAK1: oncotarget in MDS and AML
por: Beverly, Levi J., et al.
Publicado: (2014)